Preclinical News and Research

RSS
SemBioSys Genetics' Apo AI(Milano) program progress update

SemBioSys Genetics' Apo AI(Milano) program progress update

AstraZeneca signs definitive agreement to acquire Novexel

AstraZeneca signs definitive agreement to acquire Novexel

Synta Pharmaceuticals initiates STA-9090 Phase 2 clinical trial for GIST

Synta Pharmaceuticals initiates STA-9090 Phase 2 clinical trial for GIST

Viron Therapeutics' three drug candidates granted U.S. patents

Viron Therapeutics' three drug candidates granted U.S. patents

Emisphere's oral salmon calcitonin product addresses persistent musculoskeletal pain

Emisphere's oral salmon calcitonin product addresses persistent musculoskeletal pain

DSM BioSolutions to manufacture Mayoly Spindler's 'MS1819' lipase biotherapeutic

DSM BioSolutions to manufacture Mayoly Spindler's 'MS1819' lipase biotherapeutic

CSC completes a Series B financing round

CSC completes a Series B financing round

Durata Therapeutics acquires Vicuron Pharmaceuticals

Durata Therapeutics acquires Vicuron Pharmaceuticals

KVCI completes acquisition of former AAIPharma bioanalytical division

KVCI completes acquisition of former AAIPharma bioanalytical division

Flamel Technologies initiates IFN-alpha-2b XL Phase 2a clinical trial for HCV

Flamel Technologies initiates IFN-alpha-2b XL Phase 2a clinical trial for HCV

Vion Pharmaceuticals files for bankruptcy

Vion Pharmaceuticals files for bankruptcy

Proprietary adult stem cell platform, an effective treatment for diabetes, shows study

Proprietary adult stem cell platform, an effective treatment for diabetes, shows study

Phase 2 clinical study of STA-9090 in NSCLC initiated

Phase 2 clinical study of STA-9090 in NSCLC initiated

Adimab announces initiation of research collaborations with two other companies

Adimab announces initiation of research collaborations with two other companies

Alcon increases its financial support for NovaBay Pharmaceuticals' research and development efforts

Alcon increases its financial support for NovaBay Pharmaceuticals' research and development efforts

New licensing agreement to develop and commercialize prophylactic vaccine against MRSA signed

New licensing agreement to develop and commercialize prophylactic vaccine against MRSA signed

Phase 3 registration clinical trial for perifosine initiated by Keryx Biopharmaceuticals

Phase 3 registration clinical trial for perifosine initiated by Keryx Biopharmaceuticals

Syntiron grants sanofi pasteur exclusive world-wide license to its human vaccine against MRSA

Syntiron grants sanofi pasteur exclusive world-wide license to its human vaccine against MRSA

Cohera Medical announces treatment of first patient in TissuGlu study

Cohera Medical announces treatment of first patient in TissuGlu study

Keryx Biopharmaceuticals initiates Phase 3 registration clinical trial for perifosine

Keryx Biopharmaceuticals initiates Phase 3 registration clinical trial for perifosine

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.